Status:
COMPLETED
BOTOX® in the Treatment of Upper Facial Lines in Japan
Lead Sponsor:
Allergan
Conditions:
Upper Facial Rhytides
Crow's Feet Lines
Eligibility:
All Genders
20-64 years
Phase:
PHASE3
Brief Summary
This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) for the treatment of upper facial lines (Crow's Feet Lines and Frown Lines).
Eligibility Criteria
Inclusion
- Moderate to severe Crow's Feet Lines and Frown Lines
Exclusion
- Current or previous botulinum toxin treatment of any serotype
- Diagnosis of Myasthenia gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis
- Facial laser or light treatment for cosmetic purposes, microdermabrasion, superficial peels, or topical retinoid therapy or hormone cream within 3 months
- Laser treatment or phototherapy of the face for medical purposes, blepharoplasty, brow-lift or related procedure, periorbital permanent make-up, or oral retinoid therapy within one year
- Medium-depth or deep facial peels within 5 years
- Prior facial cosmetic surgery (e.g., prior periorbital surgery, facial lift, periorbital treatment with fillers, implantation or transplantation)
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT01797094
Start Date
February 1 2013
End Date
July 1 2014
Last Update
February 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tokyo, Japan